CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹258 Cr | ₹92 Cr | ₹247 Cr | ₹520 Cr | ₹824 Cr |
What is the latest Total Debt ratio of CIPLA ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹258 Cr |
| Mar2025 | ₹92 Cr |
| Mar2024 | ₹247 Cr |
| Mar2023 | ₹520 Cr |
| Mar2022 | ₹824 Cr |
How is Total Debt of CIPLA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹258 Cr | 180.10 | |
| Mar2025 | ₹92 Cr | -62.72 | |
| Mar2024 | ₹247 Cr | -52.53 | |
| Mar2023 | ₹520 Cr | -36.86 | |
| Mar2022 | ₹824 Cr | - | |
Compare Total Debt of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹116,222.2 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| MANKIND PHARMA | ₹104,275.0 Cr | -0.6% | 6.5% | 7.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -2.2% |
4.5% |
-4.4% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses